Swee Keong Yeap Selected Research

nordamnacanthal

1/2018	Subchronic toxicity, immunoregulation and anti-breast tumor effect of Nordamnacantal, an anthraquinone extracted from the stems of Morinda citrifolia L.
1/2015	Nordamnacanthal potentiates the cytotoxic effects of tamoxifen in human breast cancer cells.
8/2013	Total synthesis, cytotoxic effects of damnacanthal, nordamnacanthal and related anthraquinone analogues.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Swee Keong Yeap Research Topics

Disease

58	Neoplasms (Cancer) 05/2022 - 01/2011
44	Breast Neoplasms (Breast Cancer) 10/2021 - 04/2012
15	Inflammation (Inflammations) 07/2021 - 01/2013
12	Neoplasm Metastasis (Metastasis) 10/2021 - 01/2015
11	Body Weight (Weight, Body) 10/2021 - 06/2015
10	Infections 10/2020 - 01/2014
6	Colonic Neoplasms (Colon Cancer) 02/2021 - 06/2015
6	Obesity 01/2020 - 01/2012
4	Leukemia 06/2019 - 01/2012
4	Influenza in Birds (Avian Flu) 01/2017 - 08/2012
3	Osteosarcoma (Osteogenic Sarcoma) 10/2021 - 01/2018
3	Triple Negative Breast Neoplasms 06/2020 - 01/2017
3	Colorectal Neoplasms (Colorectal Cancer) 07/2019 - 06/2015
3	Wounds and Injuries (Trauma) 01/2019 - 01/2015
3	Carcinogenesis 01/2016 - 06/2015
2	Virus Diseases (Viral Diseases) 01/2020 - 01/2014
2	Necrosis 01/2020 - 02/2014
2	Human Influenza (Influenza) 01/2019 - 01/2015
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2014 - 01/2013
2	Adenocarcinoma 08/2012 - 04/2012
1	Neuroblastoma 06/2021
1	Disease Progression 03/2021
1	Liver Diseases (Liver Disease) 03/2021
1	Communicable Diseases (Infectious Diseases) 01/2021

Drug/Important Bio-Agent (IBA)

14	MicroRNAs (MicroRNA)IBA 05/2022 - 01/2016
14	Pharmaceutical PreparationsIBA 01/2021 - 01/2012
9	Proteins (Proteins, Gene)FDA Link 06/2021 - 01/2014
9	VaccinesIBA 01/2021 - 08/2012
9	CytokinesIBA 01/2020 - 01/2013
8	LipidsIBA 10/2021 - 01/2014
6	CurcuminIBA 06/2021 - 01/2017
6	NF-kappa B (NF-kB)IBA 06/2020 - 01/2015
6	Acetic Acid (Vinegar)FDA LinkGeneric 01/2020 - 01/2017
6	flavokawain BIBA 01/2017 - 10/2013
5	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2016
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2021 - 09/2015
5	AntioxidantsIBA 07/2021 - 01/2013
5	Messenger RNA (mRNA)IBA 10/2020 - 02/2014
5	citral (neral)IBA 06/2020 - 02/2018
5	EnzymesIBA 01/2019 - 01/2015
5	Caspase 3 (Caspase-3)IBA 10/2016 - 01/2013
4	Annexin A5IBA 01/2019 - 01/2015
4	Antineoplastic Agents (Antineoplastics)IBA 04/2018 - 01/2015
4	damnacanthalIBA 09/2016 - 08/2013
4	flavokawain AIBA 07/2015 - 10/2013
4	zerumboneIBA 01/2015 - 01/2013
3	Cisplatin (Platino)FDA LinkGeneric 04/2021 - 01/2016
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2021 - 01/2019
3	Tamoxifen FDA LinkGeneric 01/2021 - 02/2014
3	Interleukin-12 (IL 12)IBA 01/2020 - 09/2019
3	Therapeutic UsesIBA 01/2019 - 09/2016
3	Interleukin-15 (Interleukin 15)IBA 08/2018 - 08/2012
3	nordamnacanthalIBA 01/2018 - 08/2013
3	AnthraquinonesIBA 01/2018 - 08/2013
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2013
3	BromidesIBA 01/2015 - 01/2014
3	DNA VaccinesIBA 12/2013 - 08/2012
2	RNA (Ribonucleic Acid)IBA 02/2022 - 01/2020
2	ProteomeIBA 06/2021 - 01/2015
2	Estrogen ReceptorsIBA 02/2021 - 01/2021
2	cyclohexanoneIBA 02/2021 - 03/2018
2	Antiviral Agents (Antivirals)IBA 10/2020 - 01/2020
2	InterleukinsIBA 01/2020 - 01/2019
2	Biological ProductsIBA 01/2020 - 06/2014
2	FITC-annexin A5IBA 01/2020 - 01/2020
2	Hematoxylin (Haematoxylon)IBA 01/2020 - 01/2015
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2020 - 01/2015
2	eupatorinIBA 01/2020 - 01/2019
2	thiazolyl blueIBA 07/2019 - 01/2018
2	Bromelains (Bromelain)IBA 01/2019 - 01/2016
2	ImmunosorbentsIBA 01/2019 - 10/2016
2	SolutionsIBA 01/2017 - 01/2015
2	artonin EIBA 01/2017 - 01/2017
2	AdipokinesIBA 01/2017 - 01/2017
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2017 - 08/2015
2	CateninsIBA 08/2015 - 06/2015
2	AzoxymethaneIBA 08/2015 - 06/2015
2	ChemokinesIBA 03/2015 - 01/2014
2	Interleukin-18 (Interleukin 18)IBA 12/2013 - 08/2012
2	hydroxycitric acidIBA 01/2013 - 01/2012
2	Hormones (Hormone)IBA 08/2012 - 04/2012
2	Ethanol (Ethyl Alcohol)IBA 08/2012 - 04/2012
1	EucalyptolIBA 10/2021
1	Malondialdehyde (Propanedial)IBA 10/2021
1	Volatile Oils (Essential Oils)IBA 10/2021
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 06/2021
1	Neuroprotective AgentsIBA 06/2021
1	Antihypertensive Agents (Antihypertensives)IBA 05/2021
1	TanninsIBA 03/2021
1	Circulating MicroRNAIBA 11/2020
1	InterferonsIBA 10/2020
1	Macrophage Colony-Stimulating FactorIBA 06/2020
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2020
1	ChitosanIBA 01/2020

Therapy/Procedure

15	Therapeutics 03/2021 - 01/2011
5	Drug Therapy (Chemotherapy) 12/2020 - 09/2016
2	Traditional Medicine (Folk Remedies) 12/2016 - 01/2012
2	Chemoprevention 01/2014 - 01/2013
1	Radiotherapy 01/2021
1	Complementary Therapies (Alternative Medicine) 01/2021